Topics

JPM20: Orchard isn't for the picking, Biohaven's Allergan headache, and who's on Vascepa?

04:30 EST 16 Jan 2020 | BioPharmaDive

Amarin CEO John Thero had one question for investors eager to hear about his company's plans for its heart pill, while Orchard made a case for independence.

Original Article: JPM20: Orchard isn't for the picking, Biohaven's Allergan headache, and who's on Vascepa?

NEXT ARTICLE

More From BioPortfolio on "JPM20: Orchard isn't for the picking, Biohaven's Allergan headache, and who's on Vascepa?"

Quick Search

Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...